Previously, Kenvue and Shenzhen Nepstar have been cooperating in the over-the-counter (OTC) drug field in China for many ...

The French pharmaceutical company is likely to make a final decision on the unit in the coming days after reviewing the offers, Bloomberg said, citing people familiar to the matter. Both private ...

Fintel reports that on September 24, 2024, RBC Capital downgraded their outlook for Kenvue (NYSE:KVUE) from Outperform to ...

Fintel reports that on September 24, 2024, Jefferies initiated coverage of Kenvue (NYSE:KVUE) with a Buy recommendation. ...

Because this plan is a short plan based on a test of resistance it is referred to as a Short Resistance Plan. Check the time stamp on this data. Updated AI-Generated Signals for Kenvue Inc. (KVUE) ...

On Monday, Kenvue Inc (KVUE) stock saw a modest uptick, ending the day at $23.02 which represents no change from the prior close of $23.02. The stock opened at $22.83 and touched a low of $22.76 ...

Analysts split on whether Kenvue's (KVUE) reinvestment in Neutrogena could lead to market share gains. Read more here.

We suggest a new investor should avoid buying JNJ's stock now due to uncertainty surrounding its legal battles.

RBC Capital Markets analysts downgraded Kenvue (NYSE: KVUE) stock on Tuesday, citing challenges in the company's Skin Health & Beauty segment, particularly with its Neutrogena bra ...